RenovoRx Ownership | Who Owns RenovoRx?

Overview Forecast RevenueFinancials Chart Transcripts

RenovoRx Ownership Summary

RenovoRx is owned by 32.09% institutional investors, 4.37% insiders, and 63.54% retail investors. Geode capital management is the largest institutional shareholder, holding 0.95% of RNXT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.89% of its assets in RenovoRx shares.

RNXT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	RenovoRx	32.09%	4.37%	63.54%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Geode capital management	235.75K	0.95%	$304.15K
Adar1 capital management	197.25K	0.79%	$254.45K
Vanguard group	141.49K	0.57%	$182.52K
Nixon peabody trust	97.17K	0.39%	$125.34K
Renaissance	64.90K	0.26%	$83.72K
Charles schwab investment management	49.23K	0.20%	$63.51K
Citadel advisors	26.20K	0.18%	$29.60K
State street	26.15K	0.17%	$29.55K
Kestra advisory services	35.52K	0.14%	$45.82K
Blackrock	9.16K	0.06%	$10.35K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Adar1 capital management	197.25K	0.05%	$254.45K
Nixon peabody trust	97.17K	0.01%	$125.34K
Affinity capital advisors	13.28K	0.00%	$18.19K
Xtx topco	12.64K	0.00%	$16.31K
Kestra advisory services	35.52K	0.00%	$45.82K
Renaissance	64.90K	0.00%	$83.72K
Bank of america corp /de/	182.00	-	$206.00
Two sigma securities	-	-	-
Tower research capital llc (trc)	817.00	-	$1.05K
State street	26.15K	-	$29.55K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	141.49K	-	84.75K
Renaissance	64.90K	0.00%	64.90K
Citadel advisors	26.20K	-	26.20K
Xtx topco	12.64K	0.00%	12.64K
Ubs group	12.27K	-	10.03K

Top Sellers

Holder	Shares	% Assets	Change
Bank of montreal /can/	-	-	-975.00K
Adar1 capital management	197.25K	0.05%	-117.94K
Millennium management	-	-	-76.81K
Hrt financial lp	-	-	-11.74K
Two sigma securities	-	-	-11.70K

New Positions

Holder	Shares	% Assets	Change	Value
Citadel advisors	26.20K	-	26.20K	$29.60K
Xtx topco	12.64K	0.00%	12.64K	$16.31K
Jpmorgan chase	40.00	-	40.00	$52.00

Sold Out

Holder	Change
Wells fargo & company/mn	-69.00
Citigroup	-384.00
Family firm	-1.00K
Two sigma securities	-11.70K
Hrt financial lp	-11.74K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	26	44.44%	10,076,151	894.34%	32	194.41%	19	111.11%	2	-33.33%
Dec 31, 2024	12	-7.69%	848,462	-55.11%	3	5.92%	6	20.00%	2	-33.33%
Sep 30, 2024	13	-18.75%	1,890,069	111.18%	7	21.14%	5	-54.55%	3	200.00%
Jun 30, 2024	16	77.78%	895,016	171.60%	5	63.05%	11	175.00%	1	-
Mar 31, 2024	9	-18.18%	329,531	-0.47%	3	32.15%	4	-33.33%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.06M	2.89%	-
Vanguard Institutional Extnd Mkt Idx Tr	432.22K	1.18%	164.04K
Fidelity Extended Market Index	180.61K	0.51%	48.07K
Fidelity Total Market Index	78.71K	0.22%	31.56K
Schwab Total Stock Market Index	49.23K	0.13%	-
Fidelity Series Total Market Index	32.60K	0.09%	1.41K
Northern Trust Extended Eq Market Idx	25.94K	0.07%	21.01K
NT Ext Equity Mkt Idx Fd - L	25.94K	0.07%	21.01K
Vanguard Balanced Index Inv	20.70K	0.06%	-
Spartan Extended Market Index Pool E	14.88K	0.04%	1.16K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 05, 2025	Agah Ramtin	Chief Medical Officer	Buy	$29.40K
Apr 15, 2025	Agah Ramtin	Chief Medical Officer	Buy	$13.50K
Apr 15, 2025	Bagai Shaun	Chief Executive Officer	Buy	$6.82K
Apr 11, 2025	Agah Ramtin	Chief Medical Officer	Buy	$16.00K
Apr 10, 2025	Kocak Ron	VP Controller and PAO	Buy	$5.13K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	11	-
2024 Q4	-	-
2024 Q1	10	-
2023 Q4	2	-
2023 Q2	-	-

RNXT Ownership FAQ

Who Owns RenovoRx?

RenovoRx shareholders are primarily institutional investors at 32.09%, followed by 4.37% insiders and 63.54% retail investors. The average institutional ownership in RenovoRx's industry, Biotech Stocks , is 63.96%, which RenovoRx falls below.

Who owns the most shares of RenovoRx?

RenovoRx’s largest shareholders are Geode capital management (235.75K shares, 0.95%), Adar1 capital management (197.25K shares, 0.79%), and Vanguard group (141.49K shares, 0.57%). Together, they hold 2.30% of RenovoRx’s total shares outstanding.

Does Blackrock own RenovoRx?

Yes, BlackRock owns 0.06% of RenovoRx, totaling 9.16K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 10.35K$. In the last quarter, BlackRock decreased its holdings by -11.678K shares, a -56.04% change.

Who is RenovoRx’s biggest shareholder by percentage of total assets invested?

Adar1 capital management is RenovoRx’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 197.25K RenovoRx shares, valued at 254.45K$.

Who is the top mutual fund holder of RenovoRx shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of RenovoRx shares, with 2.89% of its total shares outstanding invested in 1.06M RenovoRx shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools